Results 221 to 230 of about 61,690 (282)
Some of the next articles are maybe not open access.
The platelet in cardiopulmonary bypass
The Annals of Thoracic Surgery, 1998Platelets are the smallest of the blood cells and are known to be activated during cardiopulmonary bypass. They play a role in many associated complications. Both quantitative and qualitative platelet defects have been demonstrated, resulting in microvascular hemorrhage and thromboembolism.
A, Weerasinghe, K M, Taylor
openaire +2 more sources
Journal of Thoracic and Cardiovascular Surgery, 2012 Roberta J Navickis, Mahlon M Wilkes
exaly +2 more sources
The coagulopathy of cardiopulmonary bypass
Critical Reviews in Clinical Laboratory Sciences, 2010There have been numerous publications on the coagulopathy of cardiopulmonary bypass (CPB). This review provides an introduction to the history and main components of current CPB circuits and summarizes the current knowledge of pathogenesis, prevention, and treatment of the CPB coagulopathy.
Martin W, Besser, Andrew A, Klein
openaire +2 more sources
Thromboelastography and Cardiopulmonary Bypass
Seminars in Thrombosis and Hemostasis, 2012The TEG tracks postoperative hemorrhage after CPB and is useful in guiding therapy. Its ability to characterize the overall interaction of all procoagulant participants in a final outcome (clot strength) is unique. Much work in the future is needed to establish the particular applications for TEG monitoring in CPB ...
openaire +2 more sources
Risks for impaired cerebral autoregulation during cardiopulmonary bypass and postoperative stroke
British Journal of Anaesthesia, 2012 B Joshi
exaly +2 more sources
Cardiopulmonary bypass surgery
Current Opinion in Cardiology, 1992New information on cardiopulmonary bypass continues to be produced by investigators from many disciplines. Investigations are related to problems and complications resulting from use of the heart-lung machine. The relationship of perfusion and pressure during bypass in brain, kidney, and other organs is the subject of several reports.
openaire +2 more sources
Biocompatibility in cardiopulmonary bypass
Journal of Cardiothoracic and Vascular Anesthesia, 1997Recent advances in surgical techniques and perfusion technology allow cardiac operations to be performed routinely with low mortality rates. However, patients undergoing cardiac operations with cardiopulmonary bypass (CPB) are still associated with bleeding disorders, thrombotic complications, massive fluid shifts, and the activation of blood ...
openaire +2 more sources
Cardiopulmonary Bypass in the Cat
Veterinary Surgery, 2002Objective—To assess the physiologic response to, and acute survival of, cats undergoing cardiopulmonary bypass (CPB) and to evaluate the efficacy of a commercial human pediatric oxygenator system on cats weighing less than 6 kg.Study design—Experimental study.Animals—Six intact male catsMethods—Cats were placed on cardiopulmonary bypass by cannulating ...
Jeff D, Brourman +3 more
openaire +2 more sources
Miniaturization in cardiopulmonary bypass
Perfusion, 2003Cardiopulmonary bypass (CPB) remains the key technology for more complex cardiac operations. The perfusion equipment used nowadays has seen tremendous progress since its introduction into clinical practice 50 years ago. However, overall, CPB is still far from perfect.
von Segesser LK +5 more
openaire +3 more sources
Biomaterials in cardiopulmonary bypass
Perfusion, 1994The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.
James M. Courtney +4 more
openaire +2 more sources